Derrick Rossi

[2] His father Fred worked in auto body shops for 50 years[3] and his mother Agnes co-owned a Maltese bakery.

[2] Rossi attended the Dr. Norman Bethune High School in Scarborough where he early discovered his passion for molecular biology.

[4] Rossi was involved in the foundation of Stelexis Therapeutics in 2017,[15] which develops new medication for treating cancerous stem cells.

[4] In order to avoid ethical issues related to the use and exploitation of human stem cells, Rossi based his developments on the results of Katalin Karikó and Drew Weissman on mRNA.

[18] Rossi is on record as writing of his synthetic modified mRNA: "because our technology is RNA based, it completely eliminates the risk of genomic integration and insertional mutagenesis inherent to all DNA-based methodologies.